3-[6-[[4-(Trifluoromethoxy)phenyl]amino]-4-pyrimidinyl]benzamide

3-(6-{[4-(Trifluormethoxy)phenyl]amino}-4-pyrimidinyl)benzamid

3-(6-{[4-(Trifluoromethoxy)phenyl]amino}-4-pyrimidinyl)benzamide

3-(6-{[4-(Trifluorométhoxy)phényl]amino}-4-pyrimidinyl)benzamide

3-(6-{[4-(trifluoromethoxy)phenyl]amino}pyrimidin-4-yl)benzamide

3-[6-[[4-(Trifluoromethoxy)phenyl]amino]-4-pyrimidinyl]benzamide

778270-11-4

Benzamide, 3-[6-[[4-(trifluoromethoxy)phenyl]amino]-4-pyrimidinyl]-

MFCD09265253

(3-(6)-(4-Trifluoromethoxy-phenylamino)-pyrimidin-4-yl)-benzamide

(3-(6)-(4-Trifluoromethoxy-phenylamino)-pyrimidin-4-yl)-benzamide, GNF-2, Abl Inhibitor I

3-(6-((4-(trifluoromethoxy)phenyl)amino)pyrimidin-4-yl)benzamide

3-(6-(4-(trifluoromethoxy)phenylamino)pyrimidin-4-yl)benzamide

3-[6-(4-trifluoromethoxy-phenylamino)-pyrimidin-4-yl]-benzamide

3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide

3-[6-[4-(trifluoromethoxy)anilino]pyrimidin-4-yl]benzamide

3-[6-[[4-(trifluoromethoxy)phenyl]amino]-4-pyrimidinyl]-benzamide

3-[6-[[4-(trifluoromethoxy)phenyl]amino]pyrimidin-4-yl]benzamide

ABL1_HUMAN

Bcr-abl Inhibitor

Bcr-abl Inhibitor and GNF-2

Bcr-abl inhibitor GNF-2

BCR_HUMAN

Breakpoint cluster region protein

GNF 2;GNF2

STJ

Tyrosine-protein kinase ABL1